September 20, 2014 2:28 AM ET

Pharmaceuticals

Company Overview of Dura Pharmaceuticals, Inc.

Company Overview

Dura Pharmaceuticals, Inc. was acquired by Elan Corp. plc. Dura Pharmaceuticals, Inc. engages in the development, marketing, and sale of prescription pharmaceutical products for the treatment of allergies. The company was formerly known as Immunetech Pharmaceuticals, Inc. and changed its name to Dura Pharmaceuticals, Inc. in December, 1991. Dura Pharmaceuticals, Inc. was founded in 1981 and is based in San Diego, California.

7475 Lusk Boulevard

San Diego, CA 92121

United States

Founded in 1981

1,022 Employees

Phone:

858-457-2553

Fax:

800-859-8585

Key Executives for Dura Pharmaceuticals, Inc.

Dura Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
NexusPharma, Inc. United States
Mills Biopharmaceuticals LLC United States
HealthAsure, Inc. United States
Actavis Totowa LLC United States
Wyeth Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Dura Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.